Amoxiclav (amoxicillin) powder solution for injections 500 mg/100 mg. N5 vial

$46.30

Manufacturer: Austria

Purpose: Combats bacterial infections by inhibiting cell wall synthesis. Treats severe infections.

SKU: MED56457 Category:

Description

Amoxiclav (Amoxicillin) Powder Solution for Injections 500 mg/100 mg. N5 Vial

Ingredients

Amoxicillin (500 mg) and Clavulanic Acid (100 mg).

Dosage

The usual dose is one vial injected intravenously every 8 hours.

Indications

Amoxiclav is indicated for the treatment of infections caused by susceptible bacteria. It is commonly used for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and more.

Contraindications

Do not use if allergic to penicillin or cephalosporin antibiotics. Consult a healthcare provider before use if pregnant, breastfeeding, or have any medical conditions.

Directions

Administer by intravenous injection over at least 3-4 minutes. Follow the instructions provided by a healthcare professional for accurate dosage and administration.

Scientific Evidence

Studies have shown the efficacy of Amoxiclav in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of amoxicillin-clavulanate in treating complicated urinary tract infections.

Additional Information

It is important to complete the full course of treatment as prescribed by the healthcare provider. Common side effects may include diarrhea, nausea, or rash. If severe reactions occur, discontinue use and seek medical attention.

Pharmacological Effects: Amoxiclav combines amoxicillin, a penicillin antibiotic, with clavulanic acid, a beta-lactamase inhibitor. This combination extends the spectrum of action of amoxicillin to include bacteria normally resistant to it, providing a broader antibacterial coverage.

Clinical Trials: Clinical trials have demonstrated the efficacy of Amoxiclav in various infections, showing comparable or superior effectiveness compared to other antibiotics. A study published in the International Journal of Infectious Diseases found that Amoxiclav was highly effective in treating respiratory tract infections.